148 related articles for article (PubMed ID: 9371283)
21. [Biology and clinical applications of GM-CSF].
Robak T
Acta Haematol Pol; 1994; 25(2):99-109. PubMed ID: 8067193
[TBL] [Abstract][Full Text] [Related]
22. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
23. Future uses of granulocyte-macrophage colony-stimulating factor (GM-CSF).
Jones TC
Stem Cells; 1994; 12 Suppl 1():229-39; discussion 239-40. PubMed ID: 7696962
[TBL] [Abstract][Full Text] [Related]
24. The use of granulocyte-macrophage colony-stimulating factor in bone marrow transplantation.
Armitage JO
Semin Hematol; 1992 Oct; 29(4 Suppl 3):14-8. PubMed ID: 1362821
[TBL] [Abstract][Full Text] [Related]
25. [Current status of the clinical application of hematopoietic growth factors in oncology].
Karthaus M; Ganser A
Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
[TBL] [Abstract][Full Text] [Related]
26. Experimental basis for the use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with acute myeloid leukemia.
Wörmann B; Reuter C; Zühlsdorf M; Büchner T; Hiddemann W
Semin Oncol; 1994 Dec; 21(6 Suppl 16):39-43. PubMed ID: 7801145
[TBL] [Abstract][Full Text] [Related]
27. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
Atkinson K; Vos B; Kang-Er Z; Guiffre A; Seymour R; Gillis S
Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
[TBL] [Abstract][Full Text] [Related]
28. Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma.
Vadhan-Raj S; Papadopoulos NE; Burgess MA; Linke KA; Patel SR; Hays C; Arcenas A; Plager C; Kudelka AP; Hittelman WN
J Clin Oncol; 1994 Apr; 12(4):715-24. PubMed ID: 8151315
[TBL] [Abstract][Full Text] [Related]
29. [Radioprotection of recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor on peripheral lymphocytes of rhesus monkey irradiated by 3.0 Gy gamma-rays].
Cui YF; Yang H; Luo QL; Dong B; Liu XL; Xu H; Mao BZ; Wang DW
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jan; 16(1):22-5. PubMed ID: 14706198
[TBL] [Abstract][Full Text] [Related]
30. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
[TBL] [Abstract][Full Text] [Related]
32. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
33. Effects of GM-CSF, IL-3, and GM-CSF/IL-3 fusion protein on apoptosis of human myeloid leukemic cell line Tf-1 induced by irradiation.
Yang SR; Wen L; Lu YQ; Gong QY; Yu R; Yao MH
Acta Pharmacol Sin; 2004 Jan; 25(1):68-75. PubMed ID: 14704125
[TBL] [Abstract][Full Text] [Related]
34. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
Avigan D; Wu Z; Gong J; Joyce R; Levine J; Elias A; Richardson P; Milano J; Kennedy L; Anderson K; Kufe D
Clin Cancer Res; 1999 Oct; 5(10):2735-41. PubMed ID: 10537336
[TBL] [Abstract][Full Text] [Related]
35. [Colony-stimulating factor].
Takaku F
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1216-23. PubMed ID: 3107475
[TBL] [Abstract][Full Text] [Related]
36. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
Wu HH; Talpaz M; Champlin RE; Pilat SR; Kurzrock R
Cancer; 2003 Dec; 98(11):2410-9. PubMed ID: 14635076
[TBL] [Abstract][Full Text] [Related]
37. Clinical use of GM-CSF in autologous bone marrow transplantation.
Carella AM; Gaozza E; Piatti G; Giordano D; Santini G; Carlier P; Raffo MR; Nati AS; Congin A; Bacigalupo A
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():279-82. PubMed ID: 2182740
[TBL] [Abstract][Full Text] [Related]
38. GM-CSF as an adjunct to autologous bone marrow transplantation.
Gulati S; Bennett C; Phillips J; Van-Poznak C
Stem Cells; 1993 Jan; 11(1):20-5. PubMed ID: 8457776
[TBL] [Abstract][Full Text] [Related]
39. Prospective economic evaluation accompanying a trial of GM-CSF/IL-3 in patients undergoing autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma. IL-3 BMT Study Team.
Schulman KA; Dorsainvil D; Yabroff KR; DiCesare J; Felser J; Eisenberg JM; Glick HA
Bone Marrow Transplant; 1998 Mar; 21(6):607-14. PubMed ID: 9543065
[TBL] [Abstract][Full Text] [Related]
40. [Transplantation of mesenchymal derived stem cells followed by G-CSF injection can reconstitute hematopoiesis of lethally irradiated BALB/c mice].
Hu Y; Ma L; Ma GJ; Jiang XY; Zhao CH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):20-4. PubMed ID: 12905834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]